The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3164602 40 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
The present and future disease burden of hepatitis C virus (HCV)
infections with today's treatment paradigm - volume 2
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Morbidity and mortality attributable to chronic hepatitis C virus (HCV)
infection are increasing in many countries as the infected population
ages. Models were developed for 15 countries to quantify and
characterize the viremic population, as well as estimate the number of
new infections and HCV related deaths from 2013 to 2030. Expert
consensus was used to determine current treatment levels and outcomes in
each country. In most countries, viremic prevalence has already peaked.
In every country studied, prevalence begins to decline before 2030, when
current treatment levels were held constant. In contrast, cases of
advanced liver disease and liver related deaths will continue to
increase through 2030 in most countries. The current treatment paradigm
is inadequate if large reductions in HCV related morbidity and mortality
are to be achieved.
Έτος δημοσίευσης:
2015
Συγγραφείς:
Hatzakis, A.
Chulanov, V.
Gadano, A. C.
Bergin, C. and
Ben-Ari, Z.
Mossong, J.
Schreter, I.
Baatarkhuu, O. and
Acharya, S.
Aho, I.
Anand, A. C.
Andersson, M. I. and
Arendt, V.
Arkkila, P.
Barclay, K.
Bessone, F.
Blach, S.
and Blokhina, N.
Brunton, C. R.
Choudhuri, G.
Cisneros, L.
and Croes, E. A.
Dahgwahdorj, Y. A.
Dalgard, O.
Daruich, J.
R.
Dashdorj, N. R.
Davaadorj, D.
de Knegt, R. J.
de
Vree, M.
Estes, C.
Flisiak, R.
Gane, E.
Gower, E. and
Halota, W.
Henderson, C.
Hoffmann, P.
Hornell, J. and
Houlihan, D.
Hrusovsky, S.
Jarcuska, P.
Kershenobich, D. and
Kostrzewska, K.
Kristian, P.
Leshno, M.
Lurie, Y. and
Mahomed, A.
Mamonova, N.
Mendez-Sanchez, N.
Norris, S. and
Nurmukhametova, E.
Nymadawa, P.
Oltman, M.
Oyunbileg, J. and
Oyunsuren, Ts.
Papatheodoridis, G.
Pimenov, N. and
Prabdial-Sing, N.
Prins, M.
Radke, S.
Rakhmanova, A. and
Razavi-Shearer, K.
Reesink, H. W.
Ridruejo, E.
Safadi, R.
and Sagalova, O.
Sanchez Avila, J. F.
Sanduijav, R. and
Saraswat, V.
Seguin-Devaux, C.
Shah, S. R.
Shestakova, I.
and Shevaldin, A.
Shibolet, O.
Silva, M. O.
Sokolov, S. and
Sonderup, M.
Souliotis, K.
Spearman, C. W.
Staub, T. and
Stedman, C.
Strebkova, E. A.
Struck, D.
Sypsa, V. and
Tomasiewicz, K.
Undram, L.
van der Meer, A. J.
van Santen,
D.
Veldhuijzen, I.
Villamil, F. G.
Willemse, S. and
Zuckerman, E.
Zuure, F. R.
Puri, P.
Razavi, H.
Περιοδικό:
Journal of Viral Hepatitis
Εκδότης:
Wiley
Τόμος:
22
Αριθμός / τεύχος:
1
Σελίδες:
26-45
Λέξεις-κλειδιά:
diagnosis; disease burden; epidemiology; HCV; hepatitis C; incidence;
mortality; prevalence; treatment
Επίσημο URL (Εκδότης):
DOI:
10.1111/jvh.12351
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.